Search Within

Saad Zafar Usmani

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (81)
  2. Journal Article (19)
  3. Research Letter (4)
  4. Correspondence (1)
Groups
  1. Sloan Kettering Institute Postdocs (105)
  2. Department of Medicine (99)
  3. Graduate Medical Education (95)
  4. Center for Hematologic Malignancies (94)
  5. Hematologic Malignancies, Division of (94)
  6. Myeloma (94)

More Groups

People
  1. Malin Hultcrantz (91)
  2. Alexander Lesokhin (88)
  3. Sham Mailankody (88)
  4. Carlyn Rose Tan (87)
  5. Urvi Shah (87)
  6. Hani Hassoun (86)

More People

Years
  1. 2025 (4)
  2. 2024 (32)
  3. 2023 (42)
  4. 2022 (27)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (37)
  2. Blood (35)
  3. Journal of Clinical Oncology (8)
  4. Blood Cancer Journal (7)
  5. Blood Advances (5)
  6. American Journal of Hematology (2)

More Publications

Publishers
  1. American Society of Hematology (40)
  2. Elsevier Inc. (39)
  3. American Society of Clinical Oncology (8)
  4. Nature Publishing Group (7)
  5. John Wiley & Sons, Inc. (2)
  6. Massachusetts Medical Society (2)

More Publishers

Results (105)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bone remineralization of lytic lesions in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib, lenalidomide, dexamethasone +/- daratumumab induction regimen
    Meeting Abstract

    Meseha, M.; Abusamra, M.; Farooki, A.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Shah, U.; Lu, S.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Network topology analysis reveals unique multiple myeloma genomic subtypes and potential new therapeutic targets
    Meeting Abstract

    Simhal, A.; Maclachlan, K.; Elkin, R.; Zhu, J.; Usmani, S.; Deasy, J. O.; Oh, J. H.; Tannenbaum, A.
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker for multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • African American patients with smoldering multiple myeloma may have a lower risk of progression compared to white patients
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: A retrospective study of 34 patients highlighting the need for consensus criteria
    Meeting Abstract

    Pianko, M. J.; Tiutan, T.; Derkach, A.; Jaffer-Sathick, I.; Rossi, A.; Salvatore, S.; Landau, H.; Lahoud, O.; Korde, N.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Pathogenic germline mutations in a large cohort of multiple myeloma
    Meeting Abstract

    Conry, M.; Camp, N.; Vachon, C.; Slager, S.; Hildebrandt, M.; Brown, E.; Garber, J.; Norman, A.; Stokes, S.; Lipkin, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Maintenance therapy cessation for patients with three-year sustained MRD negative remissions: Initial results from a phase II study
    Meeting Abstract

    Korde, N.; Diamond, B.; Burge, M.; Hassoun, H.; Landau, H.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Shah, U.; Maclachlan, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Geometric network analysis defines poor-prognosis subtypes in multiple myeloma
    Meeting Abstract

    Simhal, A. K.; Maclachlan, K. H.; Elkin, R.; Zhu, J.; Usmani, S.; Keats, J. J.; Norton, L.; Deasy, J. O.; Oh, J. H.; Tannenbaum, A.
    Blood (2022)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma, a real-world single center experience
    Meeting Abstract

    Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; Maclachlan, K. H.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C.; Akhlaghi, T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A randomized placebo controlled study of a plant-based dietary versus supplement versus placebo intervention in patients with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) - the Nutrition Prevention (NUTRIVENTION-3) study
    Meeting Abstract

    Shah, U. A.; Castro, F.; Anuraj, A.; Schach, E.; Derkach, A.; Joseph, N. S.; Adintori, P. A.; Guttentag, L.; Blaslov, J.; Cross, J. R.; more...
    Blood (2022)

    Fulltext@MSK | Save